Stocks Hitting 52-Week Highs

shares reached a new 52-week high of $12.84 after the company reported positive top-line data from Phase 1 Ebola vaccine trial on the WHO teleconference.

shares touched a new 52-week high of $151.84. Goldman Sachs upgraded Anacor Pharmaceuticals from Neutral to Buy and raised the price target from $60 to $195.

shares reached a new 52-week high of $10.99. Cott shares have jumped 55.38 percent over the past 52 weeks, while the S&P 500 index has gained 7.30 percent in the same period.

shares touched a new 52-week high of $16.69. PowerSecure announced an addition of $40 million in new business awards. Stephens & Co. initiated coverage on PowerSecure International with a Overweight rating and a $20.00 price target.